woundchek.com Report : Visit Site

Technical data of the woundchek.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host woundchek.com. Currently, hosted in United Kingdom and its service provider is Unlimited Web Hosting UK LTD .

the related websites

sealedenvelope.com woundsinternational.com webber-design.com 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

woundchek laboratories menu home about us products meet the team news & events contact us products first in class wound diagnostics diagnostic tests for better wound healing point of care testing in wound diagnostics news new ce mark for woundchek™ bacterial status events © copyright woundchek laboratories 2017 privacy policy | terms of service | legal notice general overview mission activities general overview previously the diagnostic division of systagenix, woundchek™ laboratories is focused on the development of novel wound diagnostics products to help improve therapeutic outcomes in wound care. currently, the cost of ineffective treatment is estimated to be $20-25 billion ¹ data based on savings calculated with the woundchek economic model, uk version, with aqp vlu data inputs. – nherera l. et al. quantifying the economic value of diagnostics in wound care in the uk. poster, ewma 2013. annually. clinical experts agree the use of point of care wound diagnostic devices could reduce the cost of ineffective treatment and delayed healing by being able to target the right therapy, on the right patient, at the right time, and for the right length of time ² world union of wound healing societies (wuwhs). principles of best practice: diagnostics and wounds. a consensus document. london: mep ltd, 2008. . a resulting financial benefit to health care systems can be achieved through significant reduction of the expenses associated with poor targeting of treatment, delayed healing, and avoidable complications. woundchek™ laboratories launched the world’s first and only point of care test to detect epa (elevated protease activity) in chronic wounds in 2012, and over the past several years has become a recognized leader in wound diagnostics. mission the company’s vision is to provide clinicians with better, accurate, timely, actionable, and easy to access information, leading to improved therapeutic outcomes through point of care wound diagnostics. woundchek™ laboratories aims to be the leading and dominant enterprise in wound diagnostics by providing medical professionals with the diagnostic information to: identify wounds which are not healing intercept issues and early warnings that cause poor wound healing or initiate wounds aid in determination of best therapeutic routes monitor the effectiveness of a course of treatment activities based in the uk and the usa, woundchek™ laboratories' staff are focused on product development, clinical research, and working with its distribution partners to develop the emerging wound diagnostics markeg. our research is centred on two critical questions, identified by clinical experts as primary pieces of diagnostic information needed to direct treatment pathways in the majority of chronic wounds: does the wound have elevated protease activity? is there an active infection? woundchek™ protease status, the world’s first and only point of care test to detect epa (elevated protease activity), was launched in 2012 and cleared for sale in europe, the middle east, south africa, and canada. iso 9001:2008 and iso 13485:2003 certified quality management system. woundchek™ protease status how to use evidence woundchek™ bacterial status the only test to detect epa developed to aid wound assessment and help clinicians target advanced wound care therapies more effectively, woundchek™ protease status is able to detect epa (elevated protease activity). as there are no visual cues for epa, wounds with epa have so far gone undetected 1 snyder r. et al. a survey: the importance of proteases in wound healing and wound assessment. poster, wounds uk 2011. . woundchek™ protease status will help clinicians establish within minutes which wounds may most benefit from a protease modulating therapy, ensuring appropriate and targeted use of these therapies. woundchek™ protease status product sizes product code description contains 350012 woundchek™ protease status test kit 12 tests (all material needed) 350065 woundchek™ protease status reagent accessory kit 3 spare reagent bottles 350010 woundchek™ protease status control kit 3 elevated result and 3 low result control swabs view instructions for use disclaimer: the product information on this page is not intended for, or to be used by health care professionals or users in the united states videos view instructions for use (pdf) disclaimer: the product information on this page is not intended for, or to be used by health care professionals or users in the united states -- videos view instructions for use (pdf) disclaimer: the product information on this page is not intended for, or to be used by health care professionals or users in the united states evidence posters & articles serena te, et al, 2016. defining a new diagnostic assessment parameter for wound care: elevated protease activity, an indicator of nonhealing, for targeted protease-modulating treatment lazaro j., et al, 2016. elevated levels of matrix metalloproteinases and chronic wound healing: an updated review of clinical evidence izzo i., et al, 2014. high matrix metalloproteinase levels are associated with dermal graph failure in diabetic foot ulcers frenthoff, e. et al. 2015. testing and treating for elevated protease activity (epa) in wound care clinics improves clinical outcome at no additional cost uccioli, l. et al. 2014. the presence of elevated protease activity (epa) influences the integration of dermal grafts in diabetic foot ulcers gibson, m. et al. 2013. testing chronic wounds for epa. the benefits of testing all wounds, whether assessed as healing or non-healing ivory, 2013. the cost implications of implementing woundchek protease status into clinical practice ivory, 2013. assessing chronic non healing wounds for elevated protease activity anichini, r. et al. 2013. detecting and treating elevated protease activity (epa) in chronic diabetic wounds duteille, f. 2013. evaluation of the use of point-of-care test for proteases to identify patients with increased risk of skin graft failure nherera, l. et al. 2013. quantifying the economic value of diagnostics in wound care in the uk international case series: using promogran/promogran prisma on wounds with elevated protease activity: case studies. london: wounds international, 2013. young, t. 2012. using a protease test to inform wound care treatment decisions haycocks, 2012. assessing chronic diabetic foot wounds for elevated protease levels hodgson, 2012. clinical skills of tissue viability nurse versus woundchek to detect elevated protease activity (epa) serena, t. et al. 2012 preliminary results: testing for elevated protease activity in clinical practice johnstone, 2012. case studies: testing for and treating epa cullen, b. et al 2012. targeted use of collagen/orc improves clinical outcome serena, t. et al. 2011. protease activity levels associated with healing status of chronic wounds snyder, r. et al. 2011. the importance of proteases in wound healing and wound assessment consensus documents diabetic foot ulcers: prevention, care and treatment spanish diabetes foundation, 2014 die tolle eines proteasen schnelltests in der wunddiagnostik dach, 2013 using a diagnostic tool to identify elevated protease activity levels in chronic and stalled wounds usa, 2013 epa made easy , wounds international, 2013. protease diagnostic in wound care uk, 2012 role of proteases in wound diagnostics international, 2012 significato e valutazione delle proeasi nel processo di riparazione tessutale italy, 2012 the role of a point-of-care protease activity diagnostic test in canadian clinical practice canada, 2012 world union of wound healing societies consensus document international 2012 symposia dr. läuchli, dr. anichini, dr. dowsett, and prof. duteille, ewma 2013 epa, guiding treatment decisions for improved clinical results and cost effective care dr. serena, dr. fletcher, and dr. läuchli, ewma 2012 testing for epa, the arrival of wound diagnostics dr. thoms, training event 2012 protea

URL analysis for woundchek.com

https://www.woundchek.com/protease-status/specimen-collection.html
https://www.woundchek.com/#ai-evidence-posters
https://www.woundchek.com/#products-woundchek
https://www.woundchek.com/#man2
https://www.woundchek.com/#products-evidence
https://www.woundchek.com/uploads/downloads/posters_articles/bacterial-protease-activity-an-indicator-of-bacterial-pathogenicity-in-chronic-wounds-even-in-the-absence-of-overt-clinical-signs.pdf
https://www.woundchek.com/uploads/downloads/consensus_documents/using-a-diagnostic-tool-to-identify-elevated-protease-activity-levels-in-chronic-and-stalled-wounds-usa.pdf
https://www.woundchek.com/#about-overview
https://www.woundchek.com/uploads/downloads/posters_articles/hodgson%20clinical%20skills%20of%20tissue%20viability%20nurse%20versus%20woundchek%20to%20detect%20elevated%20protease%20activity%202012.pdf
https://www.woundchek.com/uploads/downloads/directions/woundchek%20directions%20doncaster.pdf
https://www.woundchek.com/uploads/downloads/posters_articles/ivory%20assessing%20chronic%20non%20healing%20wounds%20for%20elevated%20protease%20activity%202013.pdf
https://www.woundchek.com/uploads/downloads/posters_articles/the-importance-of-proteases-in-wound-healing-and-wound-assessment.pdf
https://www.woundchek.com/protease-status/test-procedure.html
https://www.woundchek.com/uploads/downloads/posters_articles/evaluation-of-the-use-of-a-point-of-care-test-for-proteases-to-identify-patientes-with-increased-risk-of-skin-graft-failure.pdf
https://www.woundchek.com/uploads/downloads/posters_articles/using%20a%20protease%20test%20to%20inform%20wound%20care%20treatment%20decisions.pdf

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: WOUNDCHEK.COM
Registry Domain ID: 1645350367_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.123-reg.co.uk
Registrar URL: http://www.meshdigital.com
Updated Date: 2017-01-03T15:32:19Z
Creation Date: 2011-03-14T12:17:36Z
Registry Expiry Date: 2019-03-14T12:17:36Z
Registrar: 123-Reg Limited
Registrar IANA ID: 1515
Registrar Abuse Contact Email:
Registrar Abuse Contact Phone:
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS.123-REG.CO.UK
Name Server: NS2.123-REG.CO.UK
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2017-08-25T16:00:32Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR 123-Reg Limited

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =woundchek.com

  PORT 43

  TYPE domain

DOMAIN

  NAME woundchek.com

  CHANGED 2017-01-03

  CREATED 2011-03-14

STATUS
clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited

NSERVER

  NS.123-REG.CO.UK 212.67.202.2

  NS2.123-REG.CO.UK 62.138.132.21

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .